Analysts Set Simulations Plus, Inc. (NASDAQ:SLP) PT at $51.40

Shares of Simulations Plus, Inc. (NASDAQ:SLP) have been given an average rating of “Buy” by the seven brokerages that are presently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company. The average twelve-month target price among brokerages that have covered the stock in the last year is $51.40.

SLP has been the topic of a number of analyst reports. William Blair reiterated an “outperform” rating on shares of Simulations Plus in a research note on Wednesday, November 6th. Stephens initiated coverage on shares of Simulations Plus in a research note on Friday, November 15th. They issued an “overweight” rating and a $39.00 target price on the stock. BTIG Research reduced their price target on shares of Simulations Plus from $60.00 to $50.00 and set a “buy” rating for the company in a research report on Thursday, October 24th. StockNews.com cut Simulations Plus from a “hold” rating to a “sell” rating in a research report on Monday, November 4th. Finally, KeyCorp started coverage on Simulations Plus in a report on Monday, July 29th. They issued an “overweight” rating and a $47.00 target price for the company.

Simulations Plus Stock Performance

Shares of NASDAQ SLP opened at $31.32 on Monday. The company has a 50 day simple moving average of $30.80 and a two-hundred day simple moving average of $38.24. Simulations Plus has a fifty-two week low of $27.07 and a fifty-two week high of $51.22. The company has a market capitalization of $628.59 million, a price-to-earnings ratio of 63.92 and a beta of 0.71.

Simulations Plus (NASDAQ:SLP) last announced its quarterly earnings data on Wednesday, October 23rd. The technology company reported $0.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.04 by $0.02. Simulations Plus had a return on equity of 6.16% and a net margin of 14.15%. The business had revenue of $18.70 million during the quarter, compared to analysts’ expectations of $19.73 million. During the same quarter in the previous year, the business earned $0.18 earnings per share. The firm’s quarterly revenue was up 19.9% compared to the same quarter last year. On average, analysts forecast that Simulations Plus will post 1.12 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of the business’s stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $35.18, for a total transaction of $703,600.00. Following the completion of the sale, the director now directly owns 3,501,592 shares in the company, valued at $123,186,006.56. The trade was a 0.57 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Over the last quarter, insiders have sold 60,750 shares of company stock worth $1,905,655. 20.90% of the stock is owned by insiders.

Hedge Funds Weigh In On Simulations Plus

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Barclays PLC increased its holdings in Simulations Plus by 390.6% during the third quarter. Barclays PLC now owns 28,473 shares of the technology company’s stock valued at $911,000 after buying an additional 22,669 shares during the last quarter. Geode Capital Management LLC increased its stake in shares of Simulations Plus by 4.4% in the 3rd quarter. Geode Capital Management LLC now owns 448,618 shares of the technology company’s stock worth $14,367,000 after purchasing an additional 18,924 shares in the last quarter. First National Bank of Omaha raised its holdings in Simulations Plus by 56.1% in the 3rd quarter. First National Bank of Omaha now owns 9,704 shares of the technology company’s stock worth $311,000 after purchasing an additional 3,488 shares during the period. State Street Corp lifted its position in Simulations Plus by 4.7% during the third quarter. State Street Corp now owns 640,303 shares of the technology company’s stock valued at $20,503,000 after purchasing an additional 28,953 shares in the last quarter. Finally, Petrus Trust Company LTA bought a new stake in Simulations Plus during the third quarter valued at about $682,000. Hedge funds and other institutional investors own 78.08% of the company’s stock.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.